Microbial (Pro)TGase
 Andracon® – Recombinant Microbial Transglutaminase
 (HEPES-formulated, lyophilized)1111      Synonym 
  EC 2.3.2.13; Protein-glutamine-γ-glutamyltransferase 
     Background info 
  Andracon® is a brand for high quality microbial transglutaminase:
• Recombinantly produced in E. coli
• Ultra-pure and highly active
• Batch to batch consistent quality
• License free
• Produced according to an SOP in an ISO9001:2015 certified environment
Andracon® (Microbial Transglutaminase, MTG) catalyzes the acyl transfer reaction between γ-carboxyamide groups of peptide-bound glutamine residues and a variety or primary amines.
Therefore, Andracon® can be used to attach primary-amine coupled functional markers like biotin, fluorescent dyes, click chemistry reagents or cytotoxins to proteins, e.g. antibodies.
Essentially, Andracon® is used for the production of antibody drug conjugates (ADCs).
This product replaces T001 and T153. 
     Molecular Weight 
  38334.0 Da (theoretical, activated MTG with N-terminal sequence: FRAPDSDDR...) 
     Source 
  Recombinantly produced in E. coli. Gene derived from Streptomyces mobaraensis. 
     Specific Activity 
  > 30 U/mg 
     Appearance 
  White lyophilized solid. 
     Formulation 
  The purified transglutaminase is lyophilized from 50 mM HEPES pH 7.4. 
     Reconstitution 
  Add the volume of H2O the protein is lyophilized from (see Certificate of Analysis) to the vial of lyophilized powder. Rotate vial gently until solid dissolves. 
     Application 
  Labeling, immobilisation, conjugation, and modification of proteins. 
     Storage 
  Store at -80°C. Upon reconstitution, store working aliquots undiluted.
If storage at -80°C is not possible, storage at ≤ -20°C is recommended. 
     Reference(s) 
  Kaempffe et al., J. Pharm. Sci. 2021, S0022-3549(21)00400-7;
Früh et al., ACS Nano 2021, 15, 12161–70;
Stricker et al., J. Pediatr. Gastroenterol. Nutr. 2019, 68:e43-e50;
Spycher et al., ChemBioChem 2017, 18:1923-7;
Steffen et al., J. Biol. Chem. 2017, 292:15622-35;
Dennler et al., Chembiochem. 2015, 16:861-7;
Dennler et al., Bioconjugate Chem. 2014, 25, 569-78;
Kaufmann et al., Food Addit. Contam. Part. A 2012, 29:1364-73;
Jeger et al., Angew. Chem. Int. Ed. Engl. 2010, 49:9995-7;
Gianfrani et al., Gastroenterology 2007, 133:780-9;
Pfleiderer et al., Microbiol. Res. 2005, 160:265-71;
Ando et al., Agric. Biol. Chem. 1989, 53:2613-17;
Pasternack et al., Eur. J. Biochem. 1998, 257:570-6 
     Note 
  Always obtain, read, and observe the material safety data sheet (MSDS) precautions prior to handling or using this product.
No testing has been conducted to determine the suitability of this product for use in or on humans or animals or for in vitro diagnostic applications (e.g., in or as food, consumer goods, feed materials, cosmetics, medicinal products, medical devices). Thus, this product is not approved for any such use. If any such use of this product is intended by customer, customer will be solely responsible to obtain any necessary approvals and to meet any other requirements under applicable laws and regulations associated with such intended use. 
Change Notification of Andracon® Usage Note